Let's use relaxan's figures which appear well-based. Assuming the 3.8c EPS from 2HFY12 can at least be maintained.... then FY13 EPS is 7.2c. This equates (at SP 45c) to a PE of 5.76. Not bad for a firm with zero debt! No way it's a 'sell' at this level. Woodie contract renewal will give SP a sharpish boost.... possibly to 55c. Remains a TO target imo.
- Forums
- ASX - By Stock
- RQL
- interim results are out
interim results are out, page-12
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RQL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online